fingolimod hydrochloride has been researched along with Gastritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bromberg, JS; Chen, D; Ding, Y; Fu, S; Mao, M; Mao, X; Yopp, AC; Zhang, N | 1 |
1 other study(ies) available for fingolimod hydrochloride and Gastritis
Article | Year |
---|---|
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential.
Topics: Animals; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Division; Cell Movement; Cell Separation; Chemokine CCL19; Chemokine CCL2; Chemokines, CC; Chemotaxis; Colitis; Cytokines; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Flow Cytometry; Gastritis; L-Selectin; Lymphocyte Subsets; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Phenotype; Propylene Glycols; Receptors, CCR2; Receptors, CCR7; Receptors, Chemokine; Receptors, Interleukin-2; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine; T-Lymphocytes; Time Factors | 2004 |